Shenzhen TargetRx
Shenzhen TargetRx a Sino-American joint venture, high-tech pharmaceutical research and development company.
Launch date
Market cap
-
Enterprise valuation
CAD116—173m (Dealroom.co estimates May 2020.)
Shenzhen Guangdong (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
* | $21.2m | Series A | |
Total Funding | CAD28.9m |
Recent News about Shenzhen TargetRx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.